Whitepaper - Pharmaceutical Executive

ADVERTISEMENT

Whitepaper

Risk-Based Monitoring: The Key to Optimizing Clinical Trials

December 20, 2013

Pharmaceutical firms and CROs continue to be challenged with meeting industry guidelines set by the FDA and ICH for risk-based monitoring of clinical trials. Read about how the use of centralized and proactive analytics is integral in planning a strategy going forward.

Successful Strategic Partnering

December 1, 2013

This paper addresses how biopharmaceutical companies are turning to strategic outsourcing to address their business needs because these partnerships lower the cost of doing business, while increasing productivity and efficiency.

Multichannel: Insights for Measuring Effectiveness

October 14, 2013

This paper demonstrates how multichannel customer engagement strategy helps organizations succeed in a more complex, regulated and cost conscious market. Using on the results of a recently Cegedim Strategic Data study on sales rep detailing by channel effectiveness , this is the first in a series of whitepapers on the subject.

Genpact and AstraZeneca Reveal What It Takes to Work Together - FIVE KEYS TO SUCCESSFUL COLLABORATION

October 3, 2013

In this report, HfS examines how to build a collaborative partnership, specifically through the lens of an industry prototype that Genpact and AstraZeneca have established together. Neither organization would have been able to reap the benefits of collaboration independently, so they focused on putting in place the right team and functional structure to work together effectively as partners and generate results over time.

CFO Research: CFOs on finance- and procurement-process improvement - A report prepared by CFO Research Services in collaboration with Genpact

October 3, 2013

As part of this global benchmarking study on companies’ financial- and administrative-process performance, CFO Research Services surveyed 434 senior finance and procurement executives. Through our research, we’ve found that more than 60% of finance and procure¬ment executives agree strongly that improving their administrative-process performance would yield meaningful financial benefit to their companies.

Renewed Scrutiny: Drug Discount Program Faces Uncertain Future

October 1, 2013

Even as it is set to dramatically expand, a popular federal drug discount program known as 340B draws fresh scrutiny

Life-Cycle Marketing

July 10, 2013

Providing patient access solutions to pharmaceutical partners is no longer a one size fits all proposition. Life-cycle marketing addresses access strategies from a brands? pre-launch through patent expiry phases.

Improving Clinical Operations with Digital Signatures

November 1, 2011

The majority of large CROs and Pharmas are using digital signatures to speed clinical site initiation, reduce site monitoring reporting costs, and improve audit efficiency. See how digital signatures enable these benefits and others by allowing key players in the clinical ecosystem (site personnel, IRBs, CROs, sponsors) to electronically sign and submit reports and other documents.

EquipNet - Asset Accuracy: Know What You Have and What It's Worth

February 7, 2011

EquipNet - Asset Accuracy: Know What You Have and What It's Worth

ADVERTISEMENT

Click here